Red flags for colorectal cancer in young adults
https://www.facingourrisk.org/XRAY/red-flags-for-colorectal-cancer-in-young-adults
Full article: https://medicine.wustl.edu/news/red-flags-indicate-risk-for-early-onset-colorectal-cancer/
The rate of colorectal cancer in young adults has been increasing. Researchers in this study identified four signs or “red flags” for colorectal cancer before age 50 (considered to be early onset colorectal cancer). Recognizing these red flags can help diagnose and treat colorectal cancer earlier. (Posted 10/23/23)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- Do my symptoms put me at risk for colorectal cancer?
- When and how often should I be screened for colorectal cancer?
- Will my health insurance cover the cost of colorectal cancer screening?
- What colorectal cancer screening methods are possible, and which is best for me?
Open Clinical Trials
The following studies look at colorectal cancer screening or prevention.
- NCT04427527: Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia (ACCSIS). This study seeks to increase colorectal cancer screening in Appalachian Kentucky and Ohio.
- NCT03218423: Longitudinal Performance of Epi proColon (PERT). This study evaluates a blood test for colorectal cancer.
- NCT04940442: Outreach and Choice in Colorectal Cancer Screening. This study compares participation in colorectal cancer (CRC) screening by fecal immunochemical test [FIT] and colonoscopy.
-
NCT05078866: Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients. This study aims to see whether the Nous-209 cancer vaccine is safe to give to patients with Lynch syndrome. This study may help researchers determine whether receiving Nous-209 affects the development of polyps or tumors in the colon.
Other colorectal cancer screening and prevention studies may be found here.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.